Full-Time
Head of Performance Marketing
Posted on 8/20/2026
Hilo By Aktiia
51-200 employees
Cuffless wristband for continuous BP
No salary listed
Remote in Germany + 1 more
More locations: Berlin, Germany
Remote
Remote within Europe, with quarterly team gatherings and occasional workshops.
 Growth & Marketing (1) |
|---|
Get referred to Hilo By Aktiia
See people who can refer or advise you
- Significant experience owning paid acquisition performance in a direct-to-consumer, subscription, marketplace, consumer internet, or technology business.
- A track record from a top-tier company or team with strong products and teams.
- Deep expertise in Meta advertising and a strong understanding of Google acquisition channels.
- Experience managing substantial paid marketing budgets.
- Proven ability to scale acquisition channels while improving efficiency.
- Strong commercial and analytical thinking.
- Experience managing external agencies and holding them accountable for results.
- Practical experience using artificial intelligence tools and workflows to improve marketing performance and productivity.
- Comfort operating in fast-moving, high-growth environments.
- Own acquisition performance across Meta, Google, and Amazon.
- Manage and challenge agency partners to deliver best-in-class outcomes.
- Make investment decisions across channels based on data and business impact.
- Own cost-per-action, customer acquisition cost, and acquisition efficiency targets.
- Identify new growth opportunities and test emerging channels.
- Develop artificial-intelligence-powered workflows that improve reporting, planning, optimisation, and decision-making.
- Automate repetitive processes wherever possible.
- Continuously improve how the acquisition function operates and scales.
- Build and evolve attribution, measurement, and customer acquisition cost models.
- Establish frameworks for incrementality testing and experimentation.
- Create clear reporting and decision-making mechanisms for commercial stakeholders.
- Partner with Finance to improve visibility into marketing efficiency and growth economics.
- Work closely with Brand to improve creative performance.
- Partner with Analytics and Tracking teams to strengthen measurement.
- Collaborate with Finance on forecasting, planning, and budget allocation.
- Influence growth decisions across the wider business.
- Build a strong understanding of the acquisition ecosystem, measurement setup, and growth opportunities during the first 30 days.
- Establish trusted relationships with key stakeholders and agency partners during the first 30 days.
- Identify immediate opportunities to improve performance and efficiency during the first 30 days.
- Deliver measurable improvements in acquisition efficiency within the first year.
- Strengthen measurement and experimentation capabilities within the first year.
- Build scalable systems and artificial-intelligence-enabled workflows that increase team leverage within the first year.
- Position the business to confidently scale acquisition investment within the first year.
- Amazon advertising experience.
- Subscription or recurring-revenue business experience.
- Experience in healthcare, medtech, pharmaceutical, or other regulated industries.
- Experience building incrementality testing frameworks.
- Familiarity with Google Analytics 4, attribution platforms, Looker, Metabase, and tag management tools.
Hilo By Aktiia creates medical wearables that measure blood pressure continuously without a cuff. Its Hilo Band is a wrist-worn device that provides automated 24/7 blood pressure monitoring and has both CE marking as a Class IIa medical device and FDA 510(k) clearance for over‑the‑counter use. The product works by gathering data from onboard sensors and applying algorithms to estimate blood pressure over time, allowing users to track BP at home without manual cuff inflations. Compared with others in the space, Hilo emphasizes cuffless, continuous monitoring designed for everyday wear and has obtained regulatory clearances that support broad consumer access. The company’s goal is to expand globally and broaden product development, moving from Aktiia to Hilo to reflect its international ambitions and scale its reach in digital health and consumer medical devices.
Company Size
51-200
Company Stage
Series B
Total Funding
$117.9M
Headquarters
Neuchâtel, Switzerland
Founded
2018
Get referred to Hilo By Aktiia
See people who can refer or advise you
Simplify's Take
What believers are saying
- Hilo launched Hilo Core in the U.S. on July 21, 2026, via Amazon.
- June 2026 Series B extension added $19 million, lifting total funding above $119 million.
- February 2026 app update introduced subscription pricing and monthly calibration for recurring revenue.
What critics are saying
- Hilo Core launched as a wellness product; July 21, 2026 disclaimers deny FDA clearance.
- Monthly cuff calibration creates friction, slowing retention and subscription conversion after onboarding.
- Apple, Omron, and Withings can outspend Hilo; one regulatory challenge can kill U.S. traction.
What makes Hilo By Aktiia unique
- On July 9, 2025, Hilo became first FDA-cleared OTC cuffless blood-pressure monitor.
- Hilo's 2026 app update adds sleep, steps, and continuous BP in one system.
- The company owns 20-year research and 300 million cardiovascular datapoints from 80,000 users.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Hybrid Work Options
Company Equity
Growth & Insights and Company News
6 month growth
↓ -4%1 year growth
↑ 1%2 year growth
↑ 3%Swiss healthtech Hilo has raised $19 million in a Series B extension led by Dell Family Office, bringing total funding to over $119 million. The company is expanding its wearable blood pressure monitoring platform into the US market. Hilo's system combines a wrist-worn optical sensor, an FDA-cleared cuff, and algorithm-driven analytics to deliver 30–35 blood pressure readings daily, replacing traditional cuff measurements with continuous monitoring. The technology is built on 20 years of research and is already used by over 200,000 people globally. The company says a real-world study of 30,000 users found that highly engaged participants achieved up to five times greater reductions in systolic blood pressure over six months. The global blood pressure monitoring devices market is projected to reach $8.56 billion by 2033.
Hilo, a health technology brand developed by Aktiia, has launched Hilo Core in the US, described as the world's first blood pressure health system providing long-term insights rather than occasional snapshots. The system bridges traditional cuff-based monitors and consumer wearables. Originally developed in Switzerland, Hilo's technology is backed by over two decades of research, validated through eight clinical studies, and used by more than 200,000 people globally. The launch targets the nearly half of US adults with high blood pressure, according to American Heart Association studies. Dr Marat Fudim, associate professor of cardiology at Duke University and medical adviser to Hilo, said the system helps individuals with hypertension manage their condition through consistent, longitudinal insights, enabling earlier intervention.
European startups secured significant funding from April 28 to May 02, 2025. Key highlights include Revo Capital raising $86 million for its third fund, Aktiia (now Hilo) securing €37 million, Navro obtaining $41 million, and Pliant raising $40 million. Other notable fundings include IXI with $36.5 million, ARX Robotics with €31 million, iwell with €27 million, DePoly with $23 million, eeden with €18 million, and Chipiron with $17 million (€14.94 million).
Swiss-based Hilo, formerly Aktiia, raised €36.4M in Series B funding led by Earlybird Venture Capital and Wellington Partners. The company, which focuses on cuffless blood pressure monitoring, aims to help 100 million people manage hypertension by 2032. Hilo plans to use the funds to expand its technology, build partnerships, and increase its team. The company has grown from 20 to 60 employees globally and operates remotely in the US and Europe.
Hilo, formerly known as Aktiia, has secured $42M to develop a machine learning model for blood pressure monitoring. Traditional methods are often inconvenient and fail to capture accurate trends, highlighting the need for improved solutions.